Picton Mahoney Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-70,000
Closed -$700K 866
2022
Q1
$700K Hold
70,000
0.02% 595
2021
Q4
$693K Hold
70,000
0.02% 613
2021
Q3
$692K Hold
70,000
0.03% 568
2021
Q2
$725K Buy
+70,000
New +$725K 0.02% 575